| |
|
|
Negligible |
Low |
|
Average
|
High |
|
Extremely High |
Can not be
judged
|
Total
|
|
|
| (n=90) |
|
(n=36) |
|
(n=0) |
|
(n=4) |
|
(n=46) |
|
(n=180) |
|
| Tuberculin Skin Test |
|
|
|
|
Likelihood |
p-value |
| |
ratio |
| |
Score I (<5) |
|
| |
n |
% |
n |
% |
n |
% |
n |
% |
n |
% |
n |
% |
n |
% |
|
|
| 90 |
100.00 |
36 |
100.00 |
0 |
0.00 |
3 |
75.00 |
46 |
100.00 |
1 |
25.00 |
176 |
97.78 |
|
|
| LLR χ2(8)= |
|
| TST Score |
Score II (5-9) |
0 |
0.00 |
0 |
0.00 |
0 |
0.00 |
1 |
25.00 |
0 |
0.00 |
0 |
0.00 |
1 |
0.56 |
|
<0.001 |
| |
33.865 |
|
| |
Missed |
0 |
0.00 |
0 |
0.00 |
0 |
0.00 |
0 |
0.00 |
0 |
0.00 |
3 |
75.00 |
3 |
1.67 |
|
|
| |
0 |
(Negative- |
85 |
94.44 |
36 |
100.00 |
0 |
0.00 |
3 |
75.00 |
45 |
97.83 |
1 |
25.00 |
170 |
94.44 |
| No reaction) |
| |
|
| TST |
<5 |
(Reactive- |
5 |
5.56 |
0 |
0.00 |
0 |
0.00 |
0 |
0.00 |
1 |
2.17 |
0 |
0.00 |
6 |
3.33 |
2 |
|
| Normal) |
|
|
| cutaneous in duration size (mm) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<0.001 |
| |
|
| |
37.947 |
| 5-9 |
(Reactive- |
0 |
0.00 |
0 |
0.00 |
0 |
0.00 |
1 |
25.00 |
0 |
0.00 |
0 |
0.00 |
1 |
0.56 |
| |
| |
|
|
| Borderline) |
| |
Missed |
0 |
0.00 |
0 |
0.00 |
0 |
0.00 |
0 |
0.00 |
0 |
0.00 |
3 |
75.00 |
3 |
1.67 |
|
|
| TST adverse
reaction |
No |
|
90 |
100.00 |
36 |
100.00 |
0 |
0.00 |
4 |
100.00 |
46 |
100.00 |
1 |
25.00 |
177 |
98.33 |
LLR χ2(4)= |
<0.001 |
| Missed |
0 |
0.00 |
0 |
0.00 |
0 |
0.00 |
0 |
0.00 |
0 |
0.00 |
3 |
75.00 |
3 |
1.67 |
26.017 |
|
| |
Average LTBI category is zero (means no detected cases), Missed=excluded case due to missed follow-up or came after 5 days for reading of TST reaction, cannot be
judged means excluded cases (3 missed follow-up for TST results and one pregnant female not preformed chest X-ray due to contraindication) |
